...
首页> 外文期刊>Brazilian Journal of Otorhinolaryngology >Auditory neuropathy/auditory dyssynchrony in children with cochlear implants
【24h】

Auditory neuropathy/auditory dyssynchrony in children with cochlear implants

机译:人工耳蜗儿童的听觉神经病/听觉不同步

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The electrical stimulation generated by the Cochlear Implant (CI) may improve the neural synchrony and hence contribute to the development of auditory skills in patients with Auditory Neuropathy/Auditory Dyssynchrony (AN/AD). AIM: Prospective cohort cross-sectional study to evaluate the auditory performance and the characteristics of the electrically evoked compound action potential (ECAP) in 18 children with AN/AD and cochlear implants. MATERIAL AND METHODS: The auditory perception was evaluated by sound field thresholds and speech perception tests. To evaluate ECAP's characteristics, the threshold and amplitude of neural response were evaluated at 80Hz and 35Hz. RESULTS: No significant statistical difference was found concerning the development of auditory skills. The ECAP's characteristics differences at 80 and 35Hz stimulation rate were also not statistically significant. CONCLUSIONS: The CI was seen as an efficient resource to develop auditory skills in 94% of the AN/AD patients studied. The auditory perception benefits and the possibility to measure ECAP showed that the electrical stimulation could compensate for the neural dyssynchrony caused by the AN/AD. However, a unique clinical procedure cannot be proposed at this point. Therefore, a careful and complete evaluation of each AN/AD patient before recommending a Cochlear Implant is advised. Clinical Trials: NCT01023932
机译:人工耳蜗(CI)产生的电刺激可以改善神经同步性,因此有助于听神经病/听觉不同步症(AN / AD)患者的听觉技能发展。目的:前瞻性队列研究旨在评估18名患有AN / AD和人工耳蜗的儿童的听觉表现和电诱发的复合动作电位(ECAP)的特征。材料与方法:通过声场阈值和语音感知测试评估听觉感知。为了评估ECAP的特性,分别在80Hz和35Hz下评估了神经反应的阈值和幅度。结果:听觉技能的发展没有发现统计学差异。 ECAP在80和35Hz刺激速率下的特性差异也没有统计学意义。结论:在94%的AN / AD患者中,CI被认为是发展听觉技能的有效资源。听觉的好处和测量ECAP的可能性表明,电刺激可以弥补由AN / AD引起的神经不同步。但是,此时无法提出独特的临床程序。因此,建议在建议人工耳蜗植入之前,对每位AN / AD患者进行仔细而全面的评估。临床试验:NCT01023932

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号